'Pg ml' presentation slideshows

Bioidentical Hormone Restoration Best Medical Practice

Bioidentical Hormone Restoration Best Medical Practice. This presentation is available online. Hormone Restoration. Medically Necessary Safe Improves Health and Quality of Life Prevents and Treats Many Diseases Restores Sexuality Reduces need for:

960 views • 81 slides

Bioidentical Sex-Steroid Restoration For Women

Bioidentical Sex-Steroid Restoration For Women. Henry Lindner, MD Hormonerestoration.com. Topics. Hormones and Aging Bioidentical vs. Pharmaceutical Estradiol/Progesterone Complementarity Breast Cancer Osteoporosis Atherosclerosis and Clotting The Problems with Hormone Substitutes

819 views • 62 slides

The Nuts and Bolts of Hormone Restoration

699 views • 61 slides

Peripheral actions of the stress hormone Corticotropin Releasing Hormone (CRH):

Peripheral actions of the stress hormone Corticotropin Releasing Hormone (CRH): focus on its immunomodulatory effects. The Hypothalamic-Pituitary Adrenal (HPA) axis. Hypothalamus. CRH. VP. -. +. +. Anterior pituitary. Glucocorticoid. -. ACTH. Adrenal cortex. Sites of CRH synthesis.

759 views • 55 slides

Infections in acute exacerbation of COPD: are the agents the same ?

Infections in acute exacerbation of COPD: are the agents the same ?. Antonio Anzueto, M.D. Professor of Medicine University of Texas Health Science Center San Antonio, Texas. Outcome of AECOPD. Hospital mortality 24% Hospital mortality 6%-12%

469 views • 31 slides

Dept of Infectious Diseases Shanghai Ruijin Hospital Jiaotong University School of Medicine

Pattern Recognition Receptors and HBV Infection. Role of Toll-like Receptors. Dept of Infectious Diseases Shanghai Ruijin Hospital Jiaotong University School of Medicine Qing Xie. HBsAg rate (%). ? 8: high. 2-7: medium. <2: low. HBV infection is still a major global

443 views • 29 slides

?????????

?????????. ????????????. ? ?. ???????????????????? / ?????? ?? : ???????????????? ?? : ????????????????? ?? : ????????????????????????? ??????????????????????????????????????????????????? / ????. ???????????????????? ????????????????????????????????????????????????????????

343 views • 25 slides

Tau, Phospho-Tau et A ? 42 dans le LCR

522 views • 20 slides

Tau, Phospho-Tau et A ? 42 dans le LCR

1.32k views • 19 slides

Supplemental Figure 1

35. 30. 25. 20. 15. 10. 5. 0. Supplemental Figure 1. a. b. 800. 40. 35. 600. 30. 25. pg/ml. [RNA Sample ] / [RNA 18S ] (x10-6). 400. 20. 15. 200. 10. 5. 0. 0. Alum. Alum+CpG. Alum+CpG+323. None. Alum+CpG. Alum+CpG+323. DC+Medium. DC+323. c. ng/ml. BM-DC.

226 views • 10 slides

FSC

pDC. medium. Flu. CL097. 20 %. 85 %. 95 %. CD40. BDCA2. CD123. FSC. GEN2.2 cells. medium. Flu. CL097. 25 %. 82 %. 97 %. CD40. SSC. FSC. FSC. 100. GEN2.2. 2.5. GENshTLR7. GEN2.2. 80. GENshTLR7. 2.0. 60. % CD40 positive cells. 1.5. relative Ct. 40. 1.0. 20. 0.5.

268 views • 6 slides

Method comparison for evaluating new (improved) CD4 and viral load assays for laboratory service

Method comparison for evaluating new (improved) CD4 and viral load assays for laboratory service. Lesley Scott, PhD Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg, South Africa. Why perform evaluations?.

219 views • 6 slides

tnf- a (fold change)

Figure S1. D. A. IL-12 (pg/ml). il-12 (fold change). Cytokine (pg/ml). mRNA levels. B. E. IFN g (pg/ml). ifn- g (fold change). Donor 1. Donor 1. Donor 1. Donor 1. Donor 1. Donor 1. Cytokine (pg/ml). Donor 2. Donor 2. Donor 2. Donor 2. Donor 2. Donor 2. mRNA levels. C.

148 views • 2 slides

105 views • 1 slides

Objectives

The influence of premenopausal hysterectomy on bone mineral density Dalia F Abdulwahab 1 , Reyad Al-Baldawy 2 , Mohammed Chabek 3 , Mokhtar Awang 1 , Noraziana Abd Wahab 1 , Muna Al-Kubaisi 1

100 views • 1 slides

B.

A. B. 1400. a. a. 1200. b. 1000. c. IL-6 (pg/ ml). 800. 600. 400. d. e. 200. 0. DMSO. 25. 50. 100. 200. 400. Minocycline ( m g/ml). C. 300. MINO. DMSO. 200. IL-1 b (pg/ ml). 100. 0. Saline. LPS. 2500. d. D. 2000. c. 1500. LPS. Saline. b. BV-2 mRNA

171 views • 1 slides

TNF- a (pg/ml)

A. HSPG 30 m g/ml. medium. 3000. 2500. TNF- a (pg/ml). 2000. 1500. 1000. 500. 0. 2 h. 4 h. 12 h. 24 h. B. 3000. **. 2500. **. 2000. TNF- a (pg/ml). **. 1500. **. 1000. 500. 0. 5 m g. /. 15 m g. 30 m g. 40 m g. 100 ng. HSPG. LPS.

172 views • 1 slides

1000

IL-4. IL-5. 1500. 2000. *. pg/ml. 1500. pg/ml. 1000. 1000. 500. 500. 0. 0. medium. IL-4. medium. IL-4. IL-13. 2000. *. 1500. *. pg/ml. 1000. 500. 0. medium. IL-4. IL-2. IFN - ?. 4000. 50. 40. 3000. pg/ml. ng/ml. 30. 2000. 20. 1000. 10. 0. 0. medium.

145 views • 1 slides

Mouse splenocytes

(a). Human PBMC. Oligo only. Oligo only. Oligo only. Oligo only. Oligo only. Oligo only. Oligo only. Oligo only. Oligo only. *. DOPE:CHEMS. DOPE:CHEMS. DOPE:CHEMS. DOPE:CHEMS. DOPE:CHEMS. DOPE:CHEMS. DOPE:CHEMS. DOPE:CHEMS. DOPE:CHEMS. **. **. IFN- g (pg/ml).

179 views • 1 slides

CD45RA+

129 views • 1 slides